Literature DB >> 6127469

Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.

G de Gaetano, C Cerletti, V Bertelè.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6127469     DOI： 10.1016/s0140-6736(82)90168-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The low dose aspirin controversy solved at last?

Authors:  R D Eastham
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

Review 2.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

3.  Hypotensive and antiplatelet actions of motapizone depend on dose and time after ingestion.

Authors:  V Schulz; W Fischer; U Hanselle; W Huhmann; V Zietsch
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.

Authors:  S R Hanson; L A Harker; T D Bjornsson
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

5.  Acetylsalicylic Acid in migraine with aura prevention - a retrospective study.

Authors:  Mihaela-Bianca Anoaica; P G Anoaica; Florica Popescu
Journal:  Curr Health Sci J       Date:  2014-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.